Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2025-04-24 AGM Information
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
关于召开2024年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 100% confidence The document is a notice announcing the convening of the 2024 Annual General Meeting (AGM) of Guangdong Bawei Biotechnology Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed, and references to other related reports and announcements that are published separately on the Beijing Stock Exchange information disclosure platform. The document itself does not contain the full annual report or financial statements but rather serves as an official notification for shareholders about the AGM and the matters to be voted on. The document length is 4660 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is best classified as AGM Information (AGM-R).
2025-04-24 Chinese
第四届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the fifth meeting of the fourth board of directors of Guangdong Bawei Biotechnology Co., Ltd. It includes information about the meeting's attendance, agenda items, and voting results. The agenda items include approval of the 2024 annual report, financial statements, management reports, remuneration plans, audit reports, and other governance-related reports. The document references multiple detailed reports and announcements published separately on the Beijing Stock Exchange information disclosure platform, indicating that this document itself is a formal announcement of board meeting resolutions rather than the reports themselves. The document is over 6,800 characters, which is substantial, but it primarily serves as a formal board meeting resolution announcement. This type of document fits best under the category of Board/Management Information (MANG), as it announces decisions and changes made by the board of directors. It is not the full annual report (10-K), audit report (AR), or other detailed reports but rather the board's resolutions regarding these reports and other governance matters.
2025-04-24 Chinese
董事会审计委员会对会计师事务所履行监督职责情况报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee regarding the supervision of the accounting firm for the company's audit work for the year 2024. It details the evaluation of the audit firm's qualifications, the process of engagement, and the committee's oversight activities. It does not contain the full audit report or financial statements but rather an assessment and supervisory report on the audit firm's performance and appointment. The document length is short (1392 characters) and it is a standalone report about audit supervision, not the full annual report or audit report itself. Therefore, it fits the category of Audit Report / Information (AR). FY 2024
2025-04-24 Chinese
2024年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告 2024' which translates to 'Annual Report 2024'. It contains detailed sections typical of an annual report such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, and financial accounting reports. The document includes audited financial data, management certifications, and comprehensive financial and operational details for the fiscal year 2024. The length of the document (15,000 characters) and the depth of content confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-04-24 Chinese
天职国际会计师事务所（特殊普通合伙）关于公司2024年度控股股东及其他关联方资金占用情况的专项说明
Regulatory Filings
2025-04-24 Chinese
董事会审计委员会2024年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "Board Audit Committee 2024 Annual Performance Report" from Guangdong Bawei Biotechnology Co., Ltd. It details the audit committee's activities, meetings, evaluations of external auditors, internal audit guidance, and internal control assessments for the year 2024. The content focuses on the audit committee's oversight and governance role rather than presenting full financial statements or comprehensive annual financial results. The document length is 2462 characters, which is relatively short and more consistent with a committee report rather than a full Annual Report (10-K) or Audit Report (AR). It is not a simple announcement or certification but a detailed report on the audit committee's duties and performance. This fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and related oversight information, excluding full annual reports. Therefore, the classification is AR with high confidence. FY 2024
2025-04-24 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.